Volume 6, Issue 2 (7-2024)
pbp 2024, 6(2): 68-79 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Karimi K, Zarif Fakoor E, Ziaee T, Mehboodi M, Khodaei Ataloo P, Sanati M, et al . Antimicrobial Effects of Medicinal Plants on Streptococcus pyogenes: A Review. pbp 2024; 6 (2) :68-79
URL: http://pbp.medilam.ac.ir/article-1-243-en.html
URL: http://pbp.medilam.ac.ir/article-1-243-en.html
Kimiya Karimi1 
, Elahe Zarif Fakoor2 , Toktam Ziaee3 , Mahtab Mehboodi4 , Pouria Khodaei Ataloo5 , Masoud Sanati6 , Zeynab Mohammadi7 , Mohammadreza Dorzadeh7 , Kimia Rouzbeh *8 , Reyhaneh Heshmati9
, Elahe Zarif Fakoor2 , Toktam Ziaee3 , Mahtab Mehboodi4 , Pouria Khodaei Ataloo5 , Masoud Sanati6 , Zeynab Mohammadi7 , Mohammadreza Dorzadeh7 , Kimia Rouzbeh *8 , Reyhaneh Heshmati9
1- Department of Microbiology, Islamic Azad university, Lahijan, Iran
2- General biology, Mashhad, Iran Payam-e noor university of Mashhad, Iran
3- Department of Parasitology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
4- Department of Medical Microbiology (Bacteriology & Virology), Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
5- Department of Microbiology, School of Medicine, Ardabil University of Medical Science, Ardabil, Iran
6- Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
7- Department of Microbiology and Virology Faculty of Medicine, Tabriz university of Medical Science, Tabriz, Iran
8- Department of Developmental Biology, University of Science and Culture, ACECR, Tehran, Iran ,university.ac55@gmail.com
9- Department of Biology, Faculty of convergent Science and Technology Science and Research Branch, Islamic Azad university,Tehran, Iran
2- General biology, Mashhad, Iran Payam-e noor university of Mashhad, Iran
3- Department of Parasitology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
4- Department of Medical Microbiology (Bacteriology & Virology), Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
5- Department of Microbiology, School of Medicine, Ardabil University of Medical Science, Ardabil, Iran
6- Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
7- Department of Microbiology and Virology Faculty of Medicine, Tabriz university of Medical Science, Tabriz, Iran
8- Department of Developmental Biology, University of Science and Culture, ACECR, Tehran, Iran ,
9- Department of Biology, Faculty of convergent Science and Technology Science and Research Branch, Islamic Azad university,Tehran, Iran
Abstract: (764 Views)
Streptococcus pyogenes is a pathogen of significant public health concern. It is the most common cause of bacterial pharyngitis and is responsible for serious conditions such as streptococcal toxic shock syndrome, necrotizing fasciitis, impetigo, and scarlet fever. Additionally, S. pyogenes is involved in post-streptococcal sequelae, including acute glomerulonephritis, acute rheumatic fever, rheumatic heart disease, and reactive arthritis. The increasing antibiotic resistance of S. pyogenes has led to a growing interest in exploring alternative treatments, such as medicinal plants, which may provide effective and safer options for preventing and treating diseases caused by this bacterium. Today, there is an increasing interest in medicinal plants due to less side effects, ease of use, availability, and usually affordability. In conclusion, given the growing antibiotic resistance of Streptococcus pyogenes, this study investigates the inhibitory effects of medicinal plants against this pathogen. The aim is to assess the potential of these plants in preventing and treating diseases caused by S. pyogenes, as well as to elucidate their mechanisms of action on this bacterium.
Received: 2024/07/17 | Accepted: 2024/08/25 | Published: 2025/02/28
References
1. Avire NJ, Whiley H, Ross K. A Review of Streptococcus pyogenes: Public Health Risk Factors, Prevention and Control. Pathogens. 2021;10(2):248.
2. Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, et al. Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clinical microbiology reviews. 2014;27(2):264-301.
3. Brouwer S, Barnett TC, Rivera‐Hernandez T, Rohde M, Walker MJ. Streptococcus pyogenes adhesion and colonization. FEBS letters. 2016;590(21):3739-57.
4. Efstratiou A, Lamagni T. Epidemiology of Streptococcus pyogenes. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet] 2nd edition. 2022.
5. Ralph AP, Carapetis JR. Group a streptococcal diseases and their global burden. Host-pathogen interactions in streptococcal diseases. 2012:1-27.
6. Ibrahim J, Eisen JA, Jospin G, Coil DA, Khazen G, Tokajian S. Genome analysis of Streptococcus pyogenes associated with pharyngitis and skin infections. PLoS One. 2016;11(12):e0168177.
7. Spellerberg B, Brandt C. Laboratory diagnosis of Streptococcus pyogenes (group A streptococci). 2022.
8. Langlois DM, Andreae M. Group A streptococcal infections. Pediatrics in Review. 2011;32(10):423-30.
9. Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. Journal of clinical microbiology. 2009;47(4):1155-65.
10. LaRock DL, Johnson AF, Wilde S, Sands JS, Monteiro MP, LaRock CN. Group A Streptococcus induces GSDMA-dependent pyroptosis in keratinocytes. Nature. 2022;605(7910):527-31.
11. Ferretti JJ, Stevens DL, Fischetti VA. Streptococcus pyogenes: basic biology to clinical manifestations [Internet]. 2016.
12. You Y, Davies MR, Protani M, McIntyre L, Walker MJ, Zhang J. Scarlet fever epidemic in China caused by Streptococcus pyogenes serotype M12: epidemiologic and molecular analysis. EBioMedicine. 2018;28:128-35.
13. Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, Mosavie M, et al. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. The Lancet Infectious Diseases. 2019;19(11):1209-18.
14. Stevens DL. Invasive group A streptococcus infections. Clinical Infectious Diseases. 1992;14(1):2-13.
15. Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. New England Journal of Medicine. 2002;346(16):1200-6.
16. Quinn A, Ward K, Fischetti VA, Hemric M, Cunningham MW. Immunological relationship between the class I epitope of streptococcal M protein and myosin. Infection and immunity. 1998;66(9):4418-24.
17. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. The Lancet infectious diseases. 2005;5(11):685-94.
18. Veasy LG, Wiedmeier SE, Orsmond GS, Ruttenberg HD, Boucek MM, Roth SJ, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. New England journal of medicine. 1987;316(8):421-7.
19. Olafsdottir L, Erlendsdóttir H, Melo-Cristino J, Weinberger D, Ramirez M, Kristinsson K, et al. Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012. Eurosurveillance. 2014;19(17):20784.
20. Choby BA. Diagnosis and treatment of streptococcal pharyngitis. American family physician. 2009;79(5):383-90.
21. Kim S. Optimal diagnosis and treatment of group A streptococcal pharyngitis. Infection & Chemotherapy. 2015;47(3):202.
22. Al-Hamad AM. Streptococcal throat: Therapeutic options and macrolide resistance. Saudi Medical Journal. 2015;36(9):1128.
23. Ikebe T, Hirasawa K, Suzuki R, Isobe J, Tanaka D, Katsukawa C, et al. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections. Antimicrobial agents and chemotherapy. 2005;49(2):788-90.
24. Rahmawati N, Syukri M, Darmawi D, Zachreini I, Zulfiani U, Yusuf M, et al. Haematological Features of White Rats (Rattus norvegicus) Infected with S. pyogenes and Administered with Probiotics (Yogurt). The Scientific World Journal. 2022;2022(1):2899462.
25. Wilcox C, Stuart B, Leaver H, Lown M, Willcox M, Moore M, et al. Effectiveness of the probiotic Streptococcus salivarius K12 for the treatment and/or prevention of sore throat: a systematic review. Clinical Microbiology and Infection. 2019;25(6):673-80.
26. Di Pierro F, Adami T, Rapacioli G, Giardini N, Streitberger C. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert opinion on biological therapy. 2013;13(3):339-43.
27. Di Pierro F, Colombo M, Zanvit A, Risso P, Rottoli AS. Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children. Drug, healthcare and patient safety. 2014:15-20.
28. Tagg JR, Harold LK, Jain R, Hale JD. Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics. Frontiers in Microbiology. 2023;14:1161155.
29. Reynolds S, Pandey M, Dooley J, Calcutt A, Batzloff M, Ozberk V, et al. Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines. Scientific Reports. 2021;11(1):127.
30. Johnson AF, LaRock CN. Antibiotic treatment, mechanisms for failure, and adjunctive therapies for infections by group A Streptococcus. Frontiers in microbiology. 2021;12:760255.
31. Jin S-E, Jin H-E. Antimicrobial activity of zinc oxide nano/microparticles and their combinations against pathogenic microorganisms for biomedical applications: From physicochemical characteristics to pharmacological aspects. nanomaterials. 2021;11(2):263.
32. Gilmer DB, Schmitz JE, Euler CW, Fischetti VA. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy. 2013;57(6):2743-50.
33. Pal SK, Shukla Y. Herbal medicine: current status and the future. Asian pacific journal of cancer prevention. 2003;4(4):281-8.
34. Baradaran M, Jalali A. A Review on Antibacterial Effects of Iranian Herbal Medicine on Methicillin-Resistant Staphylococcus aureus. Jundishapur J Chronic Dis Care. 2019;8(4):e96058.
35. Abedi R, Moradkhani S, Afsharmanesh G, Rangchian M. General physicians' attitude and decision-making toward herbal medicines prescription: a scenario-based cross-sectional study in Hamadan, Iran. Journal of Herbal Medicine. 2024.
36. Wijesundara NM, Rupasinghe HPV. Bactericidal and Anti-Biofilm Activity of Ethanol Extracts Derived from Selected Medicinal Plants against Streptococcus pyogenes. Molecules. 2019;24.
37. Khahan-Yazdi I, Shabani M, Tajvidi-Monfared M, Vahidi Emami H, Mojab F, Shams S, et al. Effectiveness of medicinal plant essential oils on drug-resistant bacteria in Iran: A systematic review. Journal of Medicinal Plants. 2023.
38. Liang J, Huang X, Ma G. Antimicrobial activities and mechanisms of extract and components of herbs in East Asia. RSC Advances. 2022;12:29197 - 213.
39. Zhao S, Geng Y, Shi J, Qian J, Yang Y, Dai D, et al. Chinese herbal compound for multidrug-resistant or extensively drug-resistant bacterial pneumonia: a meta-analysis and trial sequential analysis with association rule mining to identify core herb combinations. Frontiers in Pharmacology. 2023;14:1282538.
40. Keikhaie KR, Fazeli-Nasab B, Jahantigh HR, Hassanshahian M. Antibacterial activity of ethyl acetate and methanol extracts of Securigera securidaca, Withania sominefra, Rosmarinus officinalis and Aloe vera plants against important human pathogens. Journal of Medical Bacteriology. 2018;7(1-2):13-21.
41. Siriwong S, Thumanu K, Hengpratom T, Eumkeb G. Synergy and mode of action of ceftazidime plus quercetin or luteolin on Streptococcus pyogenes. Evidence‐Based Complementary and Alternative Medicine. 2015;2015(1):759459.
42. Hamidi M, Toosi AM, Javadi B, Asili J, Soheili V, Shakeri A. In vitro antimicrobial and antibiofilm screening of eighteen Iranian medicinal plants. BMC Complementary Medicine and Therapies. 2024;24(1):135.
43. Chaughule RS, Barve RS. Role of herbal medicines in the treatment of infectious diseases. Vegetos. 2024;37(1):41-51.
44. Atapour M, Zahedi MJ, Mehrabani M, Safavi M, Keyvanfard V, Foroughi A, et al. In vitro susceptibility of the Gram-negative bacterium Helicobacter pylori to extracts of Iranian medicinal plants. Pharmaceutical Biology. 2009;47(1):77-80.
45. Sharma AN, Dewangan HK, Upadhyay PK. Comprehensive Review on Herbal Medicine: Emphasis on Current Therapy and Role of Phytoconstituents for Cancer Treatment. Chemistry & Biodiversity. 2024:e202301468.
46. Rukundo A, Omara D, Majalija S, Odur S, Alafi S, Okech SG. Antibacterial activity of ethanolic and aqueous extracts of Zingiber officinale on Streptococcus pneumoniae and Pseudomonas aeruginosa. bioRxiv. 2023:2023.01. 03.522596.
47. Varghese RM, Kumar SA, Rajeshkumar S. Antibacterial activity of herbal formulation against common oral pathogens. Bioinformation. 2023;19(5):663.
48. Sfeir J, Lefrançois C, Baudoux D, Derbré S, Licznar P. In vitro antibacterial activity of essential oils against Streptococcus pyogenes. Evidence‐Based Complementary and Alternative Medicine. 2013;2013(1):269161.
49. Heidari-Sureshjani M, Tabatabaei-Yazdi F, Alizadeh-Behbahani B, Mortazavi A. Antimicrobial effect of aqueous, ethanol, methanol and glycerin extracts of Satureja bachtiarica on Streptococcus pyogenes, Pseudomonas aeruginosa and Staphylococcus epidermidis. Zahedan journal of research in medical sciences. 2015;17(7).
50. Wijesundara NM, Rupasinghe HV. Essential oils from Origanum vulgare and Salvia officinalis exhibit antibacterial and anti-biofilm activities against Streptococcus pyogenes. Microbial pathogenesis. 2018;117:118-27.
51. Han X, Jin L, Zhao Z, Xu X, Liu S, Huang Y, et al. Combining the In Silico and In Vitro Assays to Identify Strobilanthes cusia Kuntze Bioactives against Penicillin-Resistant Streptococcus pneumoniae. Pharmaceuticals. 2023;16(1):105.
52. Adil M, Khan R, Rupasinghe HV. Application of medicinal plants as a source for therapeutic agents against Streptococcus pyogenes infections. Current Drug Metabolism. 2018;19(8):695-703.
53. Putri DPU, Dewi LM, Bestari RS. Antibacterial Effectiveness Test of Methanol Extract of Red Galangal Rhizome (Alpinia purpurata (Vieill) K. Schum) Against Streptococcus pyogenes and Klebsiella pneumonia Bacteria. Eureka Herba Indonesia. 2024;5(2):436-40.
54. Limsuwan S, Voravuthikunchai SP. Anti-Streptococcus pyogenes activity of selected medicinal plant extracts used in Thai Traditional Medicine. Tropical Journal of Pharmaceutical Research. 2013;12(4):535-40.
55. Al-Mezori HOQ, Yasin MR, Ali WN, Khedir AM. Comparative Study Of Synthetic Antibiotic Amoxicillin With Volatile Oil Extracted From Some Traditional Medicinal Plants On Bacteria Human Pathogen (Streptococcus pyogenes, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli). Journal of Pharmaceutical Negative Results. 2023:859-67.
56. Macé S, Hansen LT, Rupasinghe HV. Anti-bacterial activity of phenolic compounds against Streptococcus pyogenes. Medicines. 2017;4(2):25.
57. Manimekalai K, Srinivasan P, Dineshbabu J, Guna G, Teepica Priya Darsini D. Anti-biofilm efficacy of Plectranthus amboinicus against Streptococcus pyogenes isolated from pharyngitis patients. Asian J Pharm Clin Res. 2016;9(4):348-54.
58. Minami M, Nakamura M, Makino T. Effect of Lonicera caerulea var. emphyllocalyx extracts on murine Streptococcus pyogenes infection by modulating immune system. BioMed Research International. 2019;2019(1):1797930.
59. Lone AS, Ravindran K, Jeandet P. Evaluation of Antimicrobial activity and Bioactive compound analysis of Verbascum thapsus L. A folklore medicinal plant. Phytomedicine Plus. 2024:100560.
60. Delfani S, Mohammadrezaei-Khorramabadi R, Abbaszadeh S, Naghdi N, Shahsavari S. Phytotherapy for Streptococcus pyogenes. Journal of Pharmaceutical Sciences and Research. 2017;9(5):513.
61. Limsuwan S, Subhadhirasakul S, Voravuthikunchai SP. Medicinal plants with significant activity against important pathogenic bacteria. Pharmaceutical biology. 2009;47(8):683-9.
62. Agbo IA, Hlangothi B, Didloff J, Hattingh A, Venables L, Govender S, et al. Analysis of the correlation between phytochemical content and wound-healing potential of Lantana camara ethyl acetate and methanol extracts. Journal of Medicinal Herbs. 2023;14(2).
63. El-Shibani FA, Sulaiman GM, Abouzied AS, Al Ali A, Abdulkarim AK, Alamami AD, et al. Polyphenol fingerprint, biological activities, and in silico studies of the medicinal plant Cistus parviflorus L. extract. ACS omega. 2023;8(50):48269-79.
64. Maqbul MS, Bokhari YA, Basalib SG, Alhelali SN, Omar BMM, Khan AA, et al. A Comparative Study of Different Types of Thyme Essential Oils Against Streptococcus Pyogenes to Determine their Biochemical and Antimicrobial Properties. Oriental Journal of Chemistry. 2020;36(2):220.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |